US equities |
NVDA $237.82 ▲+1.65% SPCX $167.86 ▲+5.60% MU $1,063.29 ▼-1.08% TSLA $378.96 ▲+2.26% MSFT $525.00 ▲+1.44% SNDK $1,710.91 ▼-0.53% INTC $116.99 ▼-1.96% META $742.11 ▲+1.93%
FinancialContent

Olink Holding AB (publ) - American Depositary Shares (NQ:OLK)

26.08 UNCHANGED
Last Price Updated: 4:00 PM EDT, Jul 9, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Olink Holding AB (publ) - American Depositary Shares

< Previous 1 2 3 4 Next >
News headline image
Notice to attend the Extra General Meeting of Olink Holding AB (publ)
From Olink Proteomics AB
Via GlobeNewswire
News headline image
Thermo Fisher Scientific Completes Acquisition of Olink, Announces Commencement of Subsequent Offering Period
From Thermo Fisher Scientific Inc.
Via Business Wire
News headline image
Olink Announces Receipt of CMA Clearance for Proposed Acquisition by Thermo Fisher
From Olink Proteomics AB
Via GlobeNewswire
News headline image
Recap: Olink Holding Q4 Earnings ↗
 
Via Benzinga
News headline image
Olink Holding: Q3 Earnings Insights ↗
 
Via Benzinga
News headline image
Report from the Extra General Meeting of Olink Holding AB (publ) on 5 July 2024
From Olink Proteomics AB
Via GlobeNewswire
News headline image
Olink® Introduces Global Network of Certified Service Providers to Accelerate Protein Biomarker Discovery
From Olink Proteomics AB
Via GlobeNewswire
News headline image
Notice to attend the Extra General Meeting of Olink Holding AB (publ)
From Olink Proteomics AB
Via GlobeNewswire
News headline image
Olink® Target 48 Immune Surveillance Panel – The Next Frontier in Immune Biomarker Profiling with Absolute Confidence
From Olink Proteomics AB
Via GlobeNewswire
News headline image
Researchers Use Olink® Explore to Identify Circulating Proteins That May Give Cancer Warning 7 Years Before Diagnosis
From Olink Proteomics AB
Via GlobeNewswire
News headline image
OLK Stock Earnings: Olink Holding Beats EPS, Misses Revenue for Q1 2024 ↗
OLK stock results show that Olink Holding beat analyst estimates for earnings per share but missed on revenue for the first quarter of 2024. 
Via InvestorPlace
News headline image
Olink reports first quarter 2024 financial results
From Olink Proteomics AB
Via GlobeNewswire
News headline image
Report from the Annual General Meeting of Olink Holding AB (publ) on 19 April 2024
From Olink Proteomics AB
Via GlobeNewswire
News headline image
Olink® Insight Unveils Open-access Map of the Human Proteome, Aiding Biomarker Discovery and Understanding of Disease
From Olink Proteomics AB
Via GlobeNewswire
News headline image
OLK Stock Earnings: Olink Holding Misses EPS, Misses Revenue for Q4 2023 ↗
OLK stock results show that Olink Holding missed analyst estimates for earnings per share and missed on revenue for the fourth quarter of 2023. 
Via InvestorPlace
News headline image
Olink publishes 2023 annual report
From Olink Proteomics AB
Via GlobeNewswire
News headline image
Olink reports fourth quarter and full year 2023 financial results
From Olink Proteomics AB
Via GlobeNewswire
News headline image
Notice to attend the Annual General Meeting of Olink Holding AB (publ)
From Olink Proteomics AB
Via GlobeNewswire
News headline image
Olink announces change of date for Annual General Meeting
From Olink Proteomics AB
Via GlobeNewswire
News headline image
Forget Quantum-Si Stock, Olink Acquirer Thermo Fisher Is a Better Long-Term Investment ↗
At this juncture, the promising proteomics market is too small to be a surefire investment. 
Via The Motley Fool
News headline image
Olink reports third quarter 2023 financial results
From Olink Proteomics AB
Via GlobeNewswire
News headline image
Novogene Asia Pacific Middle East and Africa adopts Olink® Explore HT technology to accelerate multi-omics research with next generation proteomics
From Olink Proteomics AB
Via GlobeNewswire
News headline image
OLINK HOLDING INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Olink Holding AB - OLK
From Kahn Swick & Foti, LLC
Via Business Wire
News headline image
Should You Still Buy the Nasdaq's Best-Performing October Stocks? ↗
Last month's big winners were tricky to handle due to the amount of speculation investors were willing to do with them. 
Via The Motley Fool
News headline image
Top 5 Health Care Stocks That Should Keep You Up At Night ↗
The most overbought stocks in the health care sector presents an opportunity to go short on these overvalued companies. 
Via Benzinga
News headline image
OLINK HOLDING INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Olink Holding AB - OLK
From Kahn Swick & Foti, LLC
Via Business Wire
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For October 18, 2023 ↗
 
Via Benzinga
News headline image
Crude Oil Moves Lower; Bank of America Profit Beats Expectations ↗
U.S. stocks traded mostly lower toward the end of trading, with the Nasdaq Composite falling around 50 points on Tuesday. The Dow traded down 0.09% to 33,954.39 while the NASDAQ fell 0.37% to... 
Via Benzinga
Topics Stocks
News headline image
Why ServisFirst Bancshares Shares Are Trading Lower By 6%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗
Gainers SciSparc Ltd. (NASDAQ: SPRC) shares climbed 146.2% to $6.97. Aegis Capital Corp. acted as exclusive placement agent on a $5.0 million private placement for SciSparc. 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Tuesday's Intraday Session ↗
 
Via Benzinga
< Previous 1 2 3 4 Next >